A candidate molecular signature associated with tamoxifen failure in primary breast cancer

Abstract

Few markers are available that can predict response to tamoxifen treatment in estrogen receptor (ER)-positive breast cancers. Identification of such markers would be clinically useful. We attempted to identify molecular markers associated with tamoxifen failure in breast cancer. Eighteen initially ER-positive patients treated with tamoxifen requiring… (More)
DOI: 10.1186/bcr2158

Topics

13 Figures and Tables

Cite this paper

@article{Vendrell2008ACM, title={A candidate molecular signature associated with tamoxifen failure in primary breast cancer}, author={Julie A. Vendrell and Katherine E Robertson and Patrice Ravel and Susan E. Bray and Agathe Bajard and C. Purdie and Catherine Nguyen and Sirwan M. Hadad and Ivan Bi{\'e}che and Sylvie Chabaud and Thomas Bachelot and Alastair Thompson and Pascale A. Cohen}, journal={Breast Cancer Research : BCR}, year={2008}, volume={10}, pages={R88 - R88} }